Yuta Tanaka
Fujisawa, 2518555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Photoredox-based late-stage functionalization in SAR study for in vivo potent glucosylceramide synthase inhibitor.
Journal: Bioorganic & medicinal chemistry letters
Published: September 13, 2022
Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore.
Journal: Journal of medicinal chemistry
Published: February 21, 2022
A new brain-penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease.
Journal: Journal of neurochemistry
Published: April 14, 2021
New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase.
Journal: ACS medicinal chemistry letters
Published: June 16, 2020
Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase.
Journal: Journal of medicinal chemistry
Published: March 07, 2020
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
Journal: Bioorganic & medicinal chemistry
Published: December 26, 2017
Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
Journal: Journal of medicinal chemistry
Published: November 13, 2013
Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.
Journal: Bioorganic & medicinal chemistry
Published: June 13, 2012
Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility.
Journal: Bioorganic & medicinal chemistry
Published: May 25, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026